1 Prolonged apnea after succinylcholine may be due to a marked deficiency of pseudocholinesterase, the plasma enzyme that normally hydrolyzes and inactivates the drug. Low pseudocholinesterase ...

The cause - known medically as pseudocholinesterase deficiency - has now been detailed in a new medical report. The unidentified girl, of Northern European descent, underwent general anesthesia ...

Pseudocholinesterase deficiency is a condition causing a patient to be very sensitive to certain muscle relaxant medications used in anesthesia. Under normal circumstances, the medications are broken ...

HIGH susceptibility to the neuromuscular blocking action of succinylcholine is usually associated with a defective form of pseudocholinesterase in blood plasma; the abnormal enzyme is ...

Precision medicine, characterized by the personalized integration of a patient’s genetic blueprint and clinical history, represents a dynamic paradigm in healthcare evolution. The emerging field of ...

1). By the use of appropriate substrates (acetyl- and butyryl-thiocholine) and a selective inhibitor (diisopropyl-fluoro-phosphate) the enzyme has been identified as pseudocholinesterase.

This page lists all known medications that could potentially lead to 'Pseudocholinesterase deficiency' as a side effect. It's important to note that mild side effects are quite common with ...

Pseudocholinesterase deficiency is a condition that causes a defect in the production of the pseudocholinesterase enzyme. This enzyme metabolizes several anesthetic medications, such as the muscle ...

Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web ...

For research papers The BMJ has fully open peer review. This means that accepted research papers published from early 2015 onwards usually have their prepublication history posted alongside them on ...